Cue Biopharma, .
Cue Biopharma, .
Developing engineered biologics to harness the immune system for disease treatment.
About
Technology stack
detected 2026-06-30No comments yet. Be the first to share your take.
What does Cue Biopharma, . do?
Cue Biopharma is developing a novel class of engineered biologics that leverage the body's own immune system to treat a range of diseases. Their platform is designed to mimic natural biological signals, enabling the selective expansion and activation of specific immune cells, offering a targeted approach to immunotherapy.
How much funding has Cue Biopharma, . raised?
Cue Biopharma, . has raised a total of $10M in funding. The most recent round on record is Seed.
Where is Cue Biopharma, . headquartered?
Cue Biopharma, . is headquartered in Boston, United States.
When was Cue Biopharma, . founded?
Cue Biopharma, . was founded in 2017.
What industry does Cue Biopharma, . operate in?
Cue Biopharma, . operates in Biotech, Drug Discovery, Immunotherapy, Therapeutics, Biologics, Immune System.
How many employees does Cue Biopharma, . have?
Cue Biopharma, . has approximately 38 people on record.